11 HPLC method development for drug discovery LC-MS assays in rapid PK applications

Separation Science and Technology

Volumn 8, Issue , 2007, Pages 317-351

  Xu, Xiaoying ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40649127453     PISSN: 01496395     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0149-6395(07)80017-1     Document Type: Article

References (84)

1. Korfmacher W.A. Bioanalytical assays in a drug discovery environment. In: Korfmacher W. (Ed). Using Mass Spectrometry for Drug Metabolism Studies (2005), CRC Press, New York 1-26
2. Korfmacher W.A. Lead optimization strategies as part of a drug metabolism environment. Curr. Opin. Drug Discov. Dev. 6 (2003) 481-485
3. Bryant M.S., Korfmacher W.A., Wang S., Nardo C., Normeir A.A., and Lin C.C. Pharmacokinetic screening for the selection of new drug discovery candidates is greatly enhanced through the use of liquid chromatography-atmospheric pressure ionization tandem mass spectrometry. J. Chromatogr. A 777 (1997) 61-66
4. White R.E. High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 133-157
5. Korfmacher W.A., Cox K.A., Ng K., Veals J., Hsieh Y., Wainhaus S., Broske L., Prelusky D., Nomeir A., and White R.E. Cassette-accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery. Rapid Commun. Mass Spectrom. 15 (2001) 335-340
6. Cox K.A., White R.E., and Korfmacher W.A. Rapid determination of pharmacokinetic properties of new chemical entities: in vivo approaches. Comb. Chem. High Throughput Screen. 5 (2002) 29-37
7. Xu X., Lan J., and Korfmacher W.A. Rapid LC/MS/MS method development for drug discovery. Anal. Chem. 77 19 (2005) 389A-394A
8. Brotherton H.O., and Yost R.A. Determination of drugs in blood serum by mass spectrometry/mass spectrometry. Anal. Chem. 55 (1983) 549-553
9. Moseley A.M., Sheeley D.M., Blackburn R.K., Johnson R.L., and Merrill B.M. Mass spectrometry in drug discovery. In: Larsen B.S., and McEwen C.N. (Eds). Mass Spectrometry of Biological Materials (1998), Marcel Dekker, Boca Raton, FL 196-197
10. Whalen K.M., Roger K.J., Cole M.J., and Janiszewski J.S. AutoScan: an automated workstation for rapid determination of mass and tandem mass spectrometry conditions for quantitative bioanalytical mass spectrometry. Rapid Commun. Mass Spectrom. 14 (2000) 2074-2079
11. Higton D.M. A rapid, automated approach to optimization of multiple reaction monitoring conditions for quantitative bioanalytical mass spectrometry. Rapid Commun. Mass Spectrom. 15 (2001) 1922-1930
12. Wainhaus S. Rapid Pharmacokinetic Screening Using UPLC-MS/MS. NJAC-SMS Discussion Group Meeting. Somerset, NJ (2005)
13. Caporuscio C., Drexler D., D'Arienzo C., Sleczka B., Cornelius G., Wang J., Sanders M., and Olah T. Evaluating and implementing QuickQuan™ automatic LC-MS/MS method development on ThermoElectron Finnigan TSQ Quantum supporting discovery bioanalytical assays. Proceedings of the 53rd ASMS Conference on Mass Spectrometry and Allied Topics. San Antonio, TX (2005), American Society for Mass Spectrometry, New York, NY
14. Temesi D., and Law B. The effect of LC eluent composition on MS responses using electrospray ionization. LC-GC 17 (1999) 626-632
15. Finch J.W. Ultrapressure liquid chromatography. The 6th Annual Land O'Lakes Bioanalytical Conference. Merrimac, WI (2005), University of Wisconsin-Madison, Santa Fe, NM
16. Plumb R., Castro-Perez J., Granger J., Beattie I., Joncour K., and Wright A. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 18 (2004) 2331-2337
17. Churchwell M.I., Twaddle N.C., Meeker L.R., and Doerge D.R. Improving LC-MS sensitivity through increases in chromatographic performance: comparison of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 825 (2005) 134-143
18. Swartz M.Z., Granger J.H., and Plumb R.S. A novel approach for the quantification and identification of diuretics by LC/MS/MS and LC/TOF. Proceedings of the 52nd ASMS Conference on Mass Spectrometry and Allied Topics. Nashville, TN (2004), American Society for Mass Spectrometry, Madison, WI
19. Rossi D.T., and Sinz M. Mass Spectrometry in Drug Discovery (2002), Marcel Dekker, Santa Fe, NM
20. King R., Bonfiglio R., Fernandez-Metzler C., Miller-Stein C., and Olah T. Mechanistic investigation of ionization suppression in electrospray ionization. J. Am. Soc. Mass Spectrom. 11 (2000) 942-950
21. de Jonge M.E., van Dam S.M., Hillebrand M.J., Rosing H., Huitema A.D., Rodenhuis S., and Beijnen J.H. Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N′,N″-triethylenethiophosphoramide (thiotepa) and N,N′,N″-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 39 (2004) 262-271
22. Crommentuyn K.M., Rosing H., Hillebrand M.J., Huitema A.D., and Beijnen J.H. Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 804 (2004) 359-367
23. Blanchard J. Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatographic analysis. J. Chromatogr. 226 (1981) 455-460
24. Xu X., Zhou Q., and Korfmacher W. Development of a low volume plasma sample procedure for LC-MS/MS assays used for drug discovery applications. Rapid Commun. Mass Spectrom. 19 (2005) 2131-2136
25. O'Connor D., Clarke D.E., Morrison D., and Watt A.P. Determination of drug concentrations in plasma by a highly automated, generic and flexible protein precipitation and liquid chromatography/tandem mass spectrometry method applicable to the drug discovery environment. Rapid Commun. Mass Spectrom. 16 (2002) 1065-1071
26. Yang L., Wu N., Clement R.P., and Rudewicz P.J. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of SCH 211803 in rat and monkey plasma using automated 96-well protein precipitation. J. Chromatogr. B 799 (2004) 271-280
27. Zhang N., Hoffman K.L., Li W., and Rossi D.T. Semi-automated 96-well liquid-liquid extraction for quantitation of drugs in biological fluids. J. Pharm. Biomed. Anal. 22 (2000) 131-138
28. Steinborner S., and Henion J. Liquid-liquid extraction in the 96-well plate format with SRM LC/MS quantitative determination of methotrexate and its major metabolite in human plasma. Anal. Chem. 71 (1999) 2340-2345
29. Ramos L., Bakhtiar R., and Tse F.S.L. Liquid-liquid extraction using 96-well plate format in conjunction with liquid chromatography/tandem mass spectrometry for quantitative determination of methylphenidate (Ritalin) in human plasma. Rapid Commun. Mass Spectrom. 14 (2000) 740-745
30. Riffel K.A., Groff M.A., Wenning L., Song H., and Lo M.W. Fully automated liquid-liquid extraction for the determination of a novel insulin sensitizer in human plasma by heated nebulizer and turbo ionspray liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 819 (2005) 293-300
31. Zhang N., Yang A., Rogers J.D., and Zhao J.J. Quantitative analysis of simvastatin and its beta-hydroxy acid in human plasma using automated liquid-liquid extraction based on 96-well plate format and liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 34 (2004) 175-187
32. Krishnan T.R., and Ibraham I. Solid-phase extraction technique for the analysis of biological samples. J. Pharm. Biomed. Anal. 12 (1994) 287-294
33. Plumb R.S., Gray R.D., Harker A.J., and Taylor S.J. Use of reduced sorbent bed and disk membrane solid-phase extraction for the analysis of pharmaceutical compounds in biological fluids, with applications in the 96-well format. J. Chromatogr. B 687 (1996) 457-461
34. Simpson H., Berthemy A., Buhrman D., Burton R., Newton J., Kealy M., Wells D., and Wu D. High throughput liquid chromatography/mass spectrometry bioanalysis using 96-well disk solid-phase extraction plate for the sample preparation. Rapid Commun. Mass Spectrom. 12 (1998) 75-82
35. Janiszewski J., Schneider P., Hoffmaster K., Swyden M., Wells D., and Foud H. Automating sample preparation using membrane microtiter extraction for bioanalytical mass spectrometry. Rapid Commun. Mass Spectrom. 11 (1997) 1033-1037
36. Pascual J.A., and Sanagustin J. Fully automated analytical method for codeine quantification in human plasma using on-line solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 724 (1999) 295-302
37. Jemal M., Xia Y.Q., and Whigan D.B. The use of high-flow high performance liquid chromatography coupled with positive and negative ion electrospray tandem mass spectrometry for quantitative bioanalysis via direct injection of the plasma/serum samples. Rapid Commun. Mass Spectrom. 12 (1998) 1389-1399
38. Zeng H., Wu J.T., and Unger S.E. The investigation and the use of high flow column-switching LC/MS/MS as a high-throughput approach for direct plasma sample analysis of single and multiple components in pharmacokinetic studies. J. Pharm. Biomed. Anal. 27 (2002) 967-982
39. Xia Y.Q., Whigan D.B., Powell M.L., and Jamal M. Ternary-column system for high-throughput direct-injection bioanalysis by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 14 (2000) 105-111
40. Ayrton, J., Dear, G. J., Leavens, W. J., Mallett, D. N., and Plumb, R. S. (197). The use of turbulent flow chromatography/mass spectrometry for the rapid, direct analysis of a novel pharmaceutical compound in plasma. Rapid Commun. Mass Spectrom. 11, 1953-1958.
41. Hsieh Y., Wang G., Wang Y., Chackalamannil S., and Korfmacher W.A. Direct plasma analysis of drug compounds using monolithic column liquid chromatography and tandem mass spectrometry. Anal. Chem. 75 (2003) 1812-1818
42. Tanaka N., Kobayashi H., Nakanishi K., Minakuchi H., and Ishizuka N. Monolithic LC columns. Anal. Chem. 73 (2001) 420A-429A
43. Tanaka N., and Kobayashi H. Monolithic columns for liquid chromatography. Anal. Bioanal. Chem. 376 (2003) 298-301
44. Hsieh Y., Bryant M.S., Gruela G., Brisson J.M., and Korfmacher W.A. Direct analysis of plasma samples for drug discovery compounds using mixed-function column liquid chromatography tandem mass spectrometry. Rapid Commun. Mass Spectrom. 14 (2000) 1384-1390
45. Marrubini G., Coccini T., and Manzo L. Direct analysis of urinary trans,trans-muconic acid by coupled column liquid chromatography and spectrophotometric ultraviolet detection: method applicability to human urine. J. Chromatogr. B Biomed. Sci. Appl. 758 (2001) 295-303
46. Hogendoorn E.A., Westhuis K., Dijkman E., Heusinkveld H.A., den Boer A.C., Evers E.A., and Baumann R.A. Semi-permeable surface analytical reversed-phase column for the improved trace analysis of acidic pesticides in water with coupled-column reversed-phase liquid chromatography with UV detection. Determination of bromoxynil and bentazone in surface water. J. Chromatogr. A 858 (1999) 45-54
47. Mei H. Matrix effects: causes and solutions. In: Korfmacher W. (Ed). Using Mass Spectrometry for Drug Metabolism Studies (2005), CRC Press, New York, NY 103-150
48. King R., Bonfiglio R., Fernandez-Metzler C., Miller-Stein C., and Olah T. Mechanistic investigation of ionization suppression in electrospray ionization. J. Am. Soc. Mass Spectrom. 11 (2000) 942-950
49. Constantopoulos T.L., Jackson G.S., and Enke C.G. Effects of salt concentration on analyte response using electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 10 (1999) 625-634
50. Shah V.P., Midha K.K., Findlay J.W., Hill H.M., Hulse J.D., McGliveray I.J., Mckay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Bioanalytical method validation - a revisit with a decade of progress. Pharm. Res. 17 (2000) 1551-1557
51. Mei H., Hsieh Y., Nardo C., Xu X., Wang S., Ng K., and Korfmacher W.A. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery. Rapid Commun. Mass Spectrom. 17 (2003) 97-103
52. Xu X., Mei H., Wang S., Zhou Q., Wang G., Broske L., Pena A., and Korfmacher W.A. A study of common discovery dosing formulation components and their potential for causing time-dependent matrix effects in high-performance liquid chromatography tandem mass spectrometry assays. Rapid Commun. Mass Spectrom. 19 (2005) 2643-2650
53. Lipinski C. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 44 (2000) 235-249
54. Ahnoff M., Wurzer A., Lindmark B., and Jussila R. Characterisation of serum albumin and LysoPCs as major contributors to plasma sample matrix effects on electrospray ionisation efficiency. Proceedings of the 51st ASMS Conference on Mass Spectrometry and Allied Topics. Montreal, Canada (2003), American Society for Mass Spectrometry, Boca Raton, FL
55. Choi B.K., Hercules D.M., and Gusev A.I. Effect of liquid chromatography separation of complex matrices on liquid chromatography-tandem mass spectrometry signal suppression. J. Chromatogr. A 907 (2001) 337-342
56. Choi B.K., Hercules D.M., and Gusev A.I. LC-MS/MS signal suppression effects in the analysis of pesticides in complex environmental matrices. Fresenius J. Anal. Chem. 369 (2001) 370-377
57. Pascoe R., Foley J.P., and Gusev A.I. Reduction in matrix-related signal suppression effects in electrospray ionization mass spectrometry using on-line two-dimensional liquid chromatography. Anal. Chem. 73 (2001) 6014-6023
58. Matuszewski B.K., Constanzer M.L., and Chevez-Eng C.M. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal. Chem. 70 (1998) 882-889
59. Henion J., Brewer E., and Rule G. Sample preparation for LC/MS/MS: analyzing biological and environmental samples. Anal. Chem. 70 (1988) 650A-656A
60. Tong X.S., Wang J., Zheng S., Pivnichny J.V., Griffin P.R., Shen X., Donnelly M., Vakerich K., Nunes C., and Fenyk-Melody J. Effect of signal interference from dosing excipients on pharmacokinetic screening of drug candidates by liquid chromatography/mass spectrometry. Anal. Chem. 74 (2002) 6305-6313
61. Shou W.Z., and Naidong W. Post-column infusion study of the 'dosing vehicle effect' in the liquid chromatography/tandem mass spectrometric analysis of discovery pharmacokinetic samples. Rapid Commun. Mass Spectrom. 17 (2003) 589-597
62. Larger P.J., Breda M., James C.A., Hughes H.J., and Pisano R. Investigation of ion-suppression from a formulation agent in quantitative LC-MS/MS bioanalysis: a case study on Tween 80. Proceedings of the 51st ASMS Conference on Mass Spectrometry and Allied Topics. Montreal, Canada (2003), American Society for Mass Spectrometry, Santa Fe, NM
63. Hsieh Y., Chintala M., Mei H., Agans J., Brisson J.M., Ng K., and Korfmacher W.A. Quantitative screening and matrix effect studies of drug discovery compounds in monkey plasma using fast-gradient liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 15 (2001) 2481-2487
64. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75 (2003) 3019-3030
65. Bonfiglio R., King R.C., Olah T.V., and Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 13 (1999) 1175-1185
66. Tang Y.Q., Coopersmith B.I., Beato B.D., and Weng N. Strategies for dealing with matrix effects and interferences in bioanalytical LC/MS/MS. Proceedings of the 50th ASMS Conference on Mass Spectrometry and Allied Topics. Orlando, FL (2002), American Society for Mass Spectrometry, Santa Fe, NM
67. Ito S., and Tsukada K. Matrix effect and correction by standard addition in quantitative liquid chromatographic-mass spectrometric analysis of diarrhetic shellfish poisoning toxins. J. Chromatogr. A 943 (2002) 39-46
68. Ramanathan R., Su A.D., Alvarez N., Blumenkrantz N., Chowdhury S.K., Alton K., and Patrick J. Liquid chromatography/mass spectrometry methods for distinguishing N-oxides from hydroxylated compounds. Anal. Chem. 72 (2000) 1352-1359
69. Jemal M., and Xia Y.Q. The need for adequate chromatographic separation in the quantitative determination of drugs in biological samples by high performance liquid chromatography with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 13 (1999) 97
70. Weng N., Naidong W., Jiang X., Newland K., Coe R., Lin P., and Lee J. Development and validation of a sensitive method for hydromorphone in human plasma by normal phase liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 23 (2000) 697-704
71. Jemal M., and Ouyang Z. The need for chromatographic and mass resolution in liquid chromatography/tandem mass spectrometric methods used for quantitation of lactones and corresponding hydroxy acids in biological samples. Rapid Commun. Mass Spectrom. 14 (2000) 1757-1765
72. Romanyshyn L., Tiller P.R., and Hop C.E.C.A. Bioanalytical applications of 'fast chromatography' to high-throughput liquid chromatography/tandem mass spectrometric quantitation. Rapid Commun. Mass Spectrom. 14 (2000) 1662-1668
73. Fountain S.T. A mass spectrometry primer. In: Rossi D.T., and Sinz M.W. (Eds). Mass Spectrometry in Drug Discovery (2002), Marcel Dekker, Santa Fe, NM 25-84
74. Xu X. Using higher mass resolution in quantitative assays. In: Korfmacher W. (Ed). Using Mass Spectrometry for Drug Metabolism Studies (2005), CRC Press, New York, NY 203-228
75. Xu X., Veals J., and Korfmacher W.A. Comparison of conventional and enhanced mass resolution triple-quadrupole mass spectrometers for discovery bioanalytical applications. Rapid Commun. Mass Spectrom. 17 (2003) 832-837
76. Jemal M., and Ouyang Z. Enhanced resolution triple-quadrupole mass spectrometry for fast quantitative bioanalysis using liquid chromatography/tandem mass spectrometry: investigations of parameters that affect ruggedness. Rapid Commun. Mass Spectrom. 17 (2003) 24-38
77. Jemal M., and Ouyang Z. Enhanced resolution triple-quadrupole mass spectrometry for fast quantitative bioanalysis using liquid chromatography/tandem mass spectrometry: investigations of parameters that affect ruggedness. Rapid Commun. Mass Spectrom. 17 (2003) 24-38
78. Schweingruber H., Dunyach J., Olney T.N., Taylor D., Churchill M., Amad M., Winnik W., Paul G., Schoen A.E., and Campbell C. Advantages and limitations of increased mass resolution for quantitative SRM analysis on a triple stage quadrupole mass spectrometer. Proceeding of the 47th ASMS Conference on Mass Spectrometry and Allied Topics. Chicago, IL (2001), American Society for Mass Spectrometry, Boca Raton, FL
79. Yang L., Amad M., Winnik W.M., Schoen A.E., Schweingruber H., Mylchreest I., and Rudewicz P.J. Investigation of an enhanced resolution triple quadrupole mass spectrometer for high-throughput liquid chromatography/tandem mass spectrometry assays. Rapid Commun. Mass Spectrom. 16 (2002) 2060-2066
80. Paul G., Winnik W., Schmidt C., Amad M., Splendore M., Lytle C., Hughes J.E., Desai B., and MacKenzie K.I. Improving LC/ESI/SRM quantitation through high resolution on a triple quadrupole mass spectrometer. Proceeding of the 50th ASMS Conference on Mass Spectrometry and Allied Topics. Orlando, FL (2002), American Society for Mass Spectrometry, Santa Fe, NM
81. Amad M., Winnik W., Schweingruber H., Mylchreest I., and Paul G. Determination of alprazolam in the presence of polypropylene glycol utilizing the high resolution capability of a triple quadrupole mass spectrometer. Proceeding of the 49th ASMS Conference on Mass Spectrometry and Allied Topics. Chicago, IL (2001), American Society for Mass Spectrometry, Santa Fe, NM
82. Frick L.W., Adkison K.K., Wells-Knecht K.J., Woollard P., and Higton D.M. Cassette dosing: rapid in vivo assessment of pharmacokinetics. Pharm. Sci. Technol. 1 (1998) 12-18
83. Vora J., Rossi D.T., and Kindt E.K. Cassette dosing in drug discovery. In: Rossi D.T., and Sinz M.W. (Eds). Mass Spectrometry in Drug Discovery (2002), Marcel Dekker, Santa Fe, NM 357-375
84. White R.E., and Manitpisitkul P. Pharmacokinetic theory of cassette dosing in drug discovery screening. Drug Metab. Dispos. 29 (2001) 957-966